ELUTIA INC. cotiza a 0.77 USD y tiene una capitalización bursátil de $34M. En los últimos 12 meses ha facturado $12M con un margen de flujo de caja libre del -379.8%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women's Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic sc…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $-0.17 | $1.48 | $-0.09 |
| Estimado | $-0.15 | $-0.15 | $-0.14 | $-0.15 |
| Sorpresa | — | -13.3% | +1157.1% | +40.0% |
| Métrica | ELUT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 53.7% | 57.0% | -3.4% |
| Operating Margin | -218.9% | -38.6% | -180.3% |
| Net Margin | 434.2% | -33.6% | +467.8% |
| FCF Margin | -379.8% | -13.9% | -365.9% |
| ROE | 192.9% | -40.4% | +233.3% |
| ROA | 85.6% | -32.0% | +117.6% |
| Current Ratio | 2.22 | 2.84 | -0.62 |
| Debt / Equity | — | 0.28 | — |